A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Cancer
Interventions
DRUG

Sativex

Administered orally as a spray to the cheek according to a standard dose titration regimen, until patients reach a maximum tolerated dose (maximum 12 sprays per day). Each spray delivers 100 μl (Δ9tetrahydrocannabinol (THC), 27 mg/ml: Cannabidiol (CBD), 25 mg/ml).

DRUG

Placebo

Administered orally as a spray to the cheek according to a standard dose titration regimen, until patients reach a maximum tolerated dose (maximum 12 sprays per day). Each spray delivers 100 μl ethanol:propylene glycol (50:50) excipients, with peppermint oil (0.05%) flavouring and Food, Drugs \& Cosmetics (FD\&C)certified color additives; FD\&C Yellow No.5 (E102 tartrazine) (0.0260%), FD\&C Yellow No.6 (E110 sunset yellow) (0.0038%), FD\&C Red No. 40 (E129 Allura red AC) (0.00330%) and FD\&C Blue No.1 (E133 Brilliant blue FCF) (0.00058%).

Trial Locations (11)

40225

Zentrum für Neuroonkologie der Universität Duesseldorf, Düsseldorf

52074

Klinik für Onkologie, Hämatologie und Stammzelltransplantation, Universitätsklinikum Aachen RWTH, Aachen

91054

Strahlenklinik der Universität Erlangen, Erlangen

04600

Neurologie des Klinikums Altenburger Land, Altenburg

CH63 4JY

The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington

LS9 7TF

St James's Institute of Oncology, St James's University Hospital, Leeds

BS2 8ED

Bristol Haematology & Oncology Centre, Bristol

HU16 5JQ

Queen's Centre for Haematology & Oncology, Castle Hill Hospital, Cottingham

G12 0YN

West of Scotland Beatson Cancer Centre, Glasgow

SE1 7EH

Guy's & St Thomas' NHS Foundation Trust, of St Thomas' Hospital, London

M20 4BX

The Christie NHS Foundation Trust, Manchester

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY